Vitality Watch

Dossier biorxiv preclinical 12-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy

Key claim: Soluble pathogenic tau aggregates enter astrocytes, inducing mitochondrial dysfunction, cellular senescence, SASP signaling, neuronal structural impairment, and impaired neurovascular coupling in a tauopathy model.

Abstract

We previously found that soluble pathogenic tau aggregates (tau oligomers) enter brain microvascular endothelial cells and induce cellular senescence and microvascular dysfunction in a tauopathy mouse model. This study shows that soluble pathogenic tau is also transmitted to astrocytes, where it induces mitochondrial dysfunction, mediates senescence, and impairs neurovascular coupling responses. Single-cell RNA sequencing of hTau mouse cortex revealed astrocytes as one of the most transcriptionally altered cell type, showing coordinated downregulation of electron transport chain genes and upregulation of stress-induced and inflammatory markers, also elevated in hTau mouse brain and astrocyte-enriched fractions. Similar to neuron-to-neuron transmission, soluble tau aggregates entered primary human astrocytes via a heparin-sensitive process, causing microtubule destabilization, ATP depletion, and mitochondrial ROS accumulation before induction of cell-cycle-arrest-associated markers. Mitochondrial ROS scavenging with Mito TEMPO reduced tau-induced SASP cytokine activation in astrocytes in vitro and in vivo. Coculturing neurons with astrocytes undergoing tau induced senescence decreased dendritic spine density, branch level, and dendritic area in a non-cell-autonomous manner. Tau and the SASP-associated cytokines IL-1{beta} and IL-6 contributed to distinct aspects of the neuronal structural phenotype. Astrocyte-targeted SOD2 overexpression attenuated the hTau-related deficit in evoked cerebral blood flow responses; however, this partial improvement in response magnitude and duration did not achieve statistical significance compared to hTau mice expressing GFP. These results identify astrocyte senescence as a potential mechanism connecting astrocyte tau uptake, mitochondrial stress, and neuronal structural impairment. The findings motivate further study of mitochondrial antioxidant defense in tau-associated astrocyte dysfunction.

Why this matters

Most senescence and neurovascular-coupling narratives in aging brain focus on neurons, microglia, or endothelium; this finding places astrocytes as a receiver cell type in which taken-up soluble tau acutely produces mitochondrial injury, a SASP-emitting senescent state, and downstream neurovascular uncoupling in one model. That wires several previously separate mechanism pages (cellular senescence, mitochondrial dysfunction, inflammaging, vascular aging, tau axes) through a single cell-type node in tauopathy. Human translation is unestablished — this is one preclinical tauopathy model, not evidence that astrocyte-tau senescence drives Alzheimer’s-related cognitive or vascular decline in humans.

Source

Link

Briefing card

Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy
Stage: preclinical · biorxiv · 12-sep-2026

Applies to interpretation of preclinical tauopathy models: astrocytes, not just neurons and microglia, are now implicated as a cell type where soluble tau produces mitochondrial injury and senescence linked to brain blood-flow control.

Soluble pathogenic tau aggregates enter astrocytes, inducing mitochondrial dysfunction, cellular senescence, SASP signaling, neuronal structural impairment, and impaired neurovascular coupling in a tauopathy model.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.64898/2026.09.08.750215

build build 880 · 2bcef25 · 2026-11-18